← back to search

Natalie Groves

Public Health Agency · GB
Area of research
Infectious Diseases · Modeling and Simulation
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing, and COVID-19 epidemiological studies.
h-index
28
citations
10,971
works
61
NIH funding
—
primary concept
Biology
email
natalie.groves@ukhsa.gov.uk

Recent publications

APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016
Science 2023cited by 198position: middledoi
Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England
The Lancet Regional Health - Europe 2023cited by 32position: middledoi
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
The Lancet Infectious Diseases 2022cited by 175position: middledoi
Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
The Lancet Regional Health - Europe 2022cited by 31position: middledoi
Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
Nature Communications 2022cited by 18position: middledoi
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Nature 2021cited by 1,296position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Meera Chand · UK Health Security Agency4 papers (2022–2023)Mary Ramsay · National Institute for Health and Care Excellence3 papers (2022–2023)Nick Andrews · Salk Institute for Biological Studies3 papers (2022–2023)Julia Stowe · BC Centre for Disease Control3 papers (2022–2023)Jamie Lopez Bernal · Public Health Agency3 papers (2022–2023)Freja Kirsebom · Environment Agency3 papers (2022–2023)Eileen Gallagher · UK Health Security Agency1 papers (2022–2022)Andrew Rambaut · University of Edinburgh1 papers (2023–2023)Ifedayo Adetifa · Kenya Medical Research Institute1 papers (2023–2023)Ruchira Sachdeva · UK Health Security Agency1 papers (2022–2022)Daniel Maloney · University of Edinburgh1 papers (2023–2023)Kuiama Lewandowski · London School of Hygiene & Tropical Medicine1 papers (2023–2023)Rachel Lunt · UK Health Security Agency1 papers (2023–2023)Nicholas J. Loman · University of Nottingham1 papers (2023–2023)Michael Worobey · University of Arizona1 papers (2023–2023)Samuel Toffa · UK Health Security Agency1 papers (2022–2022)David J. King · University of Surrey1 papers (2023–2023)Ifeanyi F. Omah · University of Edinburgh1 papers (2023–2023)Chikwe Ihekweazu · World of Medicine (Germany)1 papers (2023–2023)Richard A. Neher · University of Basel1 papers (2023–2023)